The MSK-IMPACT analysis showed the proportion of EIF4A2 DNA amplification in CRC was only 0.8% [33], while our study found that EIF4A2 mRNA and protein expression in colorectal cancer was up to approximately 40%. The gene discussed is EIF4A2; the disease is colorectal carcinoma.